Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Oncolytic Newcastle Disease Virus"'
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/e427a26d71494416b975a566be546178
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionCervical cancer accounts for one of most common cancers among women of reproductive age. Oncolytic virotherapy has emerged as a promising immunotherapy modality but it comes with several drawbacks that include rapid clearance of virus fro
Externí odkaz:
https://doaj.org/article/05931460223740af992ba4cf7ea2d375
Autor:
Mohsen Keshavarz, Mir Saeed Ebrahimzadeh, Seyed Mohammad Miri, Hassan Dianat-Moghadam, Seyedeh Sara Ghorbanhosseini, Seyed Reza Mohebbi, Hossein Keyvani, Amir Ghaemi
Publikováno v:
Virology Journal, Vol 17, Iss 1, Pp 1-13 (2020)
Abstract Background Human papillomavirus (HPV)-associated malignancy remain a main cause of cancer in men and women. Cancer immunotherapy has represented great potential as a new promising cancer therapeutic approach. Here, we report Mesenchymal stem
Externí odkaz:
https://doaj.org/article/81afdec06196457a9541a07815e15fd6
Publikováno v:
South African Journal of Botany. 143:266-273
Digestive system cancers are common primary cancer in humans. Plants are an excellent source of compounds used in the treatment of different types of cancer. Virotherapy is a promising tool for fighting cancer because of its safety and selectivity. T
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Majid S. Jabir, Ahmed Majeed Al-Shammari, Haider Sabah Kadhim, Mohammed I. Hamzah, Ahmed Ghdhban Al-Ziaydi
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-10 (2020)
Cancer Cell International
Cancer Cell International
Background Most cancer cells exhibit increased glycolysis and use this metabolic pathway cell growth and proliferation. Targeting cancer cells’ metabolism is a promising strategy in inhibiting cancer cell progression. We used D-Mannoheptulose, a sp
Autor:
Ji Shi, Min Yuan, Songshu Meng, Chan Ding, Xiaoyan Shao, Xianling Guo, Qing Xu, Juemin Fang, Jianhua Chen, Linaer Gu, Ke Jiang, Sitong Wang, Xueke Wang
Publikováno v:
Journal of Cellular and Molecular Medicine
Oncolytic Newcastle disease virus (NDV) induces immunogenic cell death (ICD), liberating danger‐associated molecular patterns (DAMPs) that provokes defiance in neoplastic malignancy. The present study aims to investigate whether and how oncolytic N
Autor:
Amy Shergold, Shannon Burke, Robert W. Wilkinson, Matthew J. Elder, Hong Jin, Justine Whitworth, James Harper, Danielle Carroll, Xing Cheng
Publikováno v:
Cancer Immunology, Immunotherapy
Oncolytic virus (OV) therapy is an emerging approach with the potential to redefine treatment options across a range of cancer indications and in patients who remain resistant to existing standards of care, including immuno-oncology (IO) drugs. MEDI5
Autor:
Amir Sasan Mozaffari Nejad, Hossein Keyvani, Amir Ghaemi, Maryam Esghaei, Hassan Dianat-Moghadam, Farah Bokharaei-Salim, Mohsen Keshavarz
Publikováno v:
Saudi Journal of Biological Sciences, Vol 27, Iss 1, Pp 47-52 (2020)
Saudi Journal of Biological Sciences
Saudi Journal of Biological Sciences
Although Oncolytic viruses have been regarded as a promising tool for targeted therapy of cancer, accomplishing high efficacy and specificity with this strategy is challenging. Oncolytic virotherapy is one of the novel therapeutic methods recently us